| Engineered removal of PD-1 from the surface of CD19 CAR-T cells results in increased activation and diminished survival RS Kalinin, VM Ukrainskaya, SP Chumakov, AM Moysenovich, ... Frontiers in Molecular Biosciences 8, 745286, 2021 | 34 | 2021 |
| Switchable targeting of solid tumors by BsCAR T cells AV Stepanov, RS Kalinin, VO Shipunova, D Zhang, J Xie, YP Rubtsov, ... Proceedings of the National Academy of Sciences 119 (46), e2210562119, 2022 | 17 | 2022 |
| Neutrophil extracellular traps (NETs): Opportunities for targeted therapy DV Volkov, GV Tetz, YP Rubtsov, AV Stepanov, AG Gabibov Acta naturae 13 (3), 15, 2021 | 15 | 2021 |
| CAR-tropic extracellular vesicles carry tumor-associated antigens and modulate CAR T cell functionality VM Ukrainskaya, OE Musatova, DV Volkov, DS Osipova, DS Pershin, ... Scientific Reports 13 (1), 463, 2023 | 14 | 2023 |
| Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study V Ukrainskaya, O Molostova, L Shelikhova, D Pershin, E Kulakovskaya, ... Blood Advances 6 (19), 5582-5588, 2022 | 4 | 2022 |
| Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward Malignancy RS Kalinin, VO Shipunova, YP Rubtsov, VM Ukrainskay, A Schulga, ... Doklady Biochemistry and Biophysics 508 (1), 17-20, 2023 | 3 | 2023 |
| Protein tyrosine phosphatase CD45 as an immunity regulator and a potential effector of CAR-T therapy DV Volkov, VM Stepanova, YP Rubtsov, AV Stepanov, AG Gabibov Acta Naturae (англоязычная версия) 15 (3), 17-26, 2023 | 3 | 2023 |
| Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration E Malakhova, D Pershin, E Kulakovskaya, V Vedmedskaia, M Fadeeva, ... Cytotherapy 26 (6), 567-578, 2024 | 1 | 2024 |
| Modular approach to CAR-T regulation based on the barnase-barstar complex for therapy of oncological diseases R Kalinin, V Shipunova, I Chernikov, D Volkov, A Shulga, S Deyev, ... FEBS Open Bio 11, 93-93, 2021 | 1 | 2021 |
| Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning VM Stepanova, DV Volkov, DS Osipova, W Wang, Y Hou, DE Pershin, ... Molecular Therapy Oncology 32 (3), 2024 | | 2024 |
| Barnase interactions with barstar tune CART-cells activity against solid tumors R Kalinin, V Shipunova, I Chernikov, A Moysenovich, D Volkov, A Shulga, ... FEBS OPEN BIO 12, 191-191, 2022 | | 2022 |
| CD45 knockout as a strategy for generation universal T and CART cells D Volkov, V Ukrainskaya, D Osipova, D Pershin, M Maschan, A Stepanov FEBS OPEN BIO 12, 193-193, 2022 | | 2022 |
| Intracellular PD-1 interception for adoptive immunotherapy against PD-L1 positive cancers V Knorre, R Kalinin, S Chumakov, V Tereshchuk, D Volkov, ... FEBS OPEN BIO 11, 298-298, 2021 | | 2021 |
| DNaseI based approach for enhanced CAR-T action against solid cancers D Volkov, A Stepanov FEBS OPEN BIO 11, 410-410, 2021 | | 2021 |
Yury RubtsovAssistant Professor Institute of Bioorganic Chemistry RAS在 ibch.ru 的电子邮件经过验证
